Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAF8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
KCNJ15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CIDEC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPAG5-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
AP1M2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGF11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BNC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LY6G5C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOSL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFAP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYBRD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP3R2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFP92 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on